FundingVenture Capital5 MIN READ

China's MegaRobo Raises Nearly $200 Million From Oman's Sovereign Fund and Others to Scale AI-Powered Lab Automation

Suzhou-based MegaRobo, which builds robotic laboratory automation and "AI for Science" systems, has raised nearly $200 million in a round that included the Oman Investment Authority, CMB International, Asia Investment Capital, Granite Asia and Sinovation Ventures, the company said on November 19. It has now raised about $600 million in total.

By Nisha Omkumar · Author20 November 2026New
China's MegaRobo Raises Nearly $200 Million From Oman's Sovereign Fund and Others to Scale AI-Powered Lab Automation

Scientific research has long depended on skilled people performing repetitive experiments by hand. A Chinese startup is betting that robots and artificial intelligence can do much of that work faster and more reliably.

MegaRobo, a company based in Suzhou, China, has raised nearly $200 million in a new funding round, the company announced on Thursday, November 19, China time. Investors included the Oman Investment Authority, Oman's sovereign wealth fund, along with CMB International, Asia Investment Capital, Granite Asia, Sinovation Ventures and several investors based in Suzhou.

The company has now raised about $600 million in total.

What MegaRobo does

MegaRobo develops robotic systems that automate laboratory work, combined with AI software that designs and analyses experiments, an approach often described as "AI for Science." Its systems can carry out tasks such as handling samples, mixing chemicals and running tests, while AI models help decide which experiments to run next based on the results.

The company serves customers in life sciences, including pharmaceutical and biotechnology companies, as well as in industrial sectors. It has also applied its technology to defect diagnosis in semiconductor and display manufacturing, where identifying tiny flaws quickly is critical to production yields.

MegaRobo says it serves more than 500 customers in one segment and more than 200 in another, according to the company's own figures, which could not be independently verified.

Why lab automation matters

Laboratory research is often slow, expensive and labour-intensive. Scientists spend significant time on routine tasks, and experiments can be difficult to reproduce. Automated labs can run experiments around the clock, with greater precision and consistency, and generate large amounts of data that AI models can learn from.

Combining automation with AI creates what some call "self-driving labs," where systems can design, run and analyse experiments with minimal human intervention. This approach could accelerate discoveries in drug development, materials science and chemistry.

Gulf capital flows into Asian tech

The participation of the Oman Investment Authority highlights a growing trend of Gulf sovereign wealth funds investing in Asian technology companies. Funds from Saudi Arabia, the UAE, Qatar and Oman have increased investments in China, India and Southeast Asia, seeking to diversify their portfolios and gain exposure to fast-growing technology sectors.

For Asian startups, Gulf investors offer large pools of patient capital and potential access to Middle Eastern markets, where governments are investing heavily in research, healthcare and technology as part of economic diversification plans.

China's AI for Science push

China has made AI for Science a strategic priority, seeing it as a way to accelerate innovation in areas such as pharmaceuticals, new materials and advanced manufacturing. Chinese companies and research institutes have invested heavily in automated labs and AI models for scientific research.

The global race in AI for Science involves major technology companies, such as Google DeepMind, whose AlphaFold system predicted protein structures, and startups in the US, Europe and Asia. This week, Isomorphic Labs, a DeepMind spinout focused on AI drug discovery, has been in the spotlight after raising significant capital.

The investors

CMB International is the investment arm of China Merchants Bank. Granite Asia, formerly known as GGV Capital's Asia business, invests in technology companies across Asia. Sinovation Ventures was founded by Kai-Fu Lee, a prominent AI expert and former head of Google China.

“The labs of the future may be run as much by robots and algorithms as by scientists in white coats.”
— TIGI Startups Desk

The challenges

Lab automation companies face challenges, including the high cost of robotic systems, the complexity of integrating with existing lab equipment and workflows, and the need to demonstrate clear return on investment to customers. Scientific research is highly varied, making it difficult to build systems that work across different types of experiments.

Chinese technology companies also face geopolitical headwinds, including US export controls on advanced chips and restrictions on investments in certain Chinese technology sectors, which could limit access to some markets and technologies.

2dbaa170-ace1-4791-b862-648b6abd6d69.png

What it means for India

India has a large pharmaceutical industry and a growing biotechnology sector, which could benefit from lab automation and AI for Science. Indian companies and research institutions are beginning to adopt automated labs, and several Indian startups are working in this area. The success of companies like MegaRobo highlights the potential of the sector and the competition Indian firms will face.

Why semiconductors and displays

In semiconductor and display manufacturing, even microscopic defects can render products unusable, reducing production yields and raising costs. Manufacturers use inspection systems to detect flaws, but analysing the causes of defects and adjusting production processes is complex and often requires expert engineers.

AI systems that can automatically diagnose the root causes of defects could help factories improve yields faster, which is particularly valuable for China as it seeks to build a self-sufficient semiconductor industry.

Oman's investment strategy

The Oman Investment Authority manages the sultanate's sovereign wealth and has sought to invest in technology and innovation, both abroad and at home, as part of Oman Vision 2040, the country's economic diversification plan. Investing in companies such as MegaRobo can also bring technology and expertise that could benefit Oman's own research and industrial ambitions.

Gulf funds have become increasingly important sources of capital for Asian startups as Western investors have grown more cautious about China.

The robotics boom in China

China has become a global leader in robotics, from industrial robots used in factories to humanoid robots and specialised systems for logistics, healthcare and research. The government has identified robotics as a strategic industry, and Chinese companies have attracted significant investment.

Lab automation is one of several niches where Chinese robotics companies are seeking to compete with established Western suppliers.

What scientists gain

For scientists, lab automation promises to free them from repetitive manual work and allow them to focus on designing experiments and interpreting results. Automated systems can also improve the reproducibility of research, a long-standing challenge in many scientific fields, by performing procedures in exactly the same way every time.

Researchers say the combination of robotics and AI could dramatically increase the number of experiments that can be run, accelerating the pace of discovery in fields such as drug development, battery chemistry and materials science. However, adoption requires investment in new equipment and training, and many labs are still at an early stage of automation.

What comes next

MegaRobo will use the funding to expand its products, grow its customer base and potentially enter new international markets. Its progress will be watched as an indicator of how quickly AI-powered automation can transform scientific research.

TagsMegaRoboChinaSuzhoulab automationAI for ScienceroboticsOman Investment Authoritysovereign wealth fundCMB InternationalGranite AsiaSinovation Ventureslife sciencesdrug discoverysemiconductorsdisplay manufacturingventure capitaldeeptechGulf investorsAsia fundinginvestors

Reader reviews

Sign in to rate and review this article.
Loading reviews…